{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:51:12Z","timestamp":1792727472186,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010090","name":"Women and Children's Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.vaccine.2020.02.044","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T18:02:05Z","timestamp":1582308125000},"page":"3003-3007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Prior vaccination with recombinant Vesicular Stomatitis Virus \u2013 Zaire Ebolavirus vaccine is associated with improved survival among patients with Ebolavirus infection"],"prefix":"10.1016","volume":"38","author":[{"given":"Masumbuko Claude","family":"Kasereka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin D.","family":"Ericson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukaba","family":"Tumba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombeni Didier","family":"Mwesha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.02.044_b0005","unstructured":"WHO. Ebola situation reports: Democratic Republic of the Congo [accessed November 25, 2019]; 2019. Available from: https:\/\/www.who.int\/emergencies\/diseases\/ebola\/drc-2019\/situation-reports."},{"issue":"7747","key":"10.1016\/j.vaccine.2020.02.044_b0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/d41586-019-00805-7","article-title":"Violence propels Ebola outbreak towards 1,000 cases","volume":"567","author":"Maxmen","year":"2019","journal-title":"Nature"},{"issue":"10156","key":"10.1016\/j.vaccine.2020.02.044_b0015","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(18)32419-X","article-title":"Ebola virus epidemic in war-torn eastern DR Congo","volume":"392","author":"Claude","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.02.044_b0020","unstructured":"WHO. Ebola outbreak in the Democratic Republic of the Congo declared public health emergency of international concern [accessed August 29th, 2019]; 2019. Available from: https:\/\/www.who.int\/news-room\/detail\/17-07-2019-ebola-outbreak-in-the-democratic-republic-of-the-congo-declared-a-public-health-emergency-of-international-concern."},{"issue":"10068","key":"10.1016\/j.vaccine.2020.02.044_b0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.02.044_b0030","unstructured":"Group, P.I.W., et al., A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N Engl J Med 2013; 75(15): p. 1448\u20131456."},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.044_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/v11040326","article-title":"Mechanism of inhibition of Ebola Virus RNA-dependent RNA polymerase by Remdesivir","volume":"11","author":"Tchesnokov","year":"2019","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.vaccine.2020.02.044_b0040","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S1473-3099(18)30397-9","article-title":"Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study","volume":"18","author":"Sivapalasingam","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.044_b0045","doi-asserted-by":"crossref","unstructured":"Ebola success, Moon bears and gene-therapy delay. Nature 2019; 572(7769): p. 288\u2013289.","DOI":"10.1038\/d41586-019-02416-8"},{"issue":"10174","key":"10.1016\/j.vaccine.2020.02.044_b0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(19)30036-4","article-title":"Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study","volume":"393","author":"Gaudinski","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2020.02.044_b0055","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1473-3099(19)30291-9","article-title":"Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis","volume":"19","author":"McMullan","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2020.02.044_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142216","article-title":"Analytical performance characteristics of the Cepheid GeneXpert Ebola assay for the detection of Ebola Virus","volume":"10","author":"Pinsky","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.044_b0065","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.044_b0070","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/ndt\/gft277","article-title":"A new equation to estimate the glomerular filtration rate in children, adolescents and young adults","volume":"29","author":"Hoste","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.044_b0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/ndt\/gfv454","article-title":"An estimated glomerular filtration rate equation for the full age spectrum","volume":"31","author":"Pottel","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.vaccine.2020.02.044_b0080","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S1473-3099(15)00144-9","article-title":"Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study","volume":"15","author":"Hunt","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.044_b0085","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2018. URL https:\/\/www.R-project.org\/."},{"issue":"12","key":"10.1016\/j.vaccine.2020.02.044_b0090","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1172\/JCI83111","article-title":"Blood kinetics of Ebola virus in survivors and nonsurvivors","volume":"125","author":"Lanini","year":"2015","journal-title":"J Clin Invest"},{"issue":"16","key":"10.1016\/j.vaccine.2020.02.044_b0095","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.vaccine.2019.03.004","article-title":"Ebola epidemic in war-torn Democratic Republic of Congo, 2018: Acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine","volume":"37","author":"Kasereka","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.044_b0100","unstructured":"WHO. Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of an Ebola outbreak in the Democratic Republic of the Congo: an example of integration of research into epidemic response [accessed November 25, 2019]; 2019. Available from: https:\/\/www.who.int\/csr\/resources\/publications\/ebola\/ebola-ring-vaccination-results-12-april-2019.pdf."},{"issue":"24","key":"10.1016\/j.vaccine.2020.02.044_b0105","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.02.044_b0110","unstructured":"WHO. Strategic response plan for the Ebola virus disease outbreak in the provinces of North Kivu and Ituri [accessed November 25, 2019]; 2019. Available from: https:\/\/www.who.int\/emergencies\/crises\/cod\/drc-ebola-srp-v20190219-en.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2020.02.044_b0115","unstructured":"SAGE. SAGE interm recommendations on vaccination against ebola virus disease (EVD) [accessed November 25, 2019]; 2019. Available from: https:\/\/www.who.int\/immunization\/interim_ebola_recommendations_feb_2019.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2020.02.044_b0120","unstructured":"Branswell H. Ebola vaccine will be provided to women who are pregnant, marking reversal in policy [accessed November 25, 2019]; 2019. Available from: https:\/\/www.statnews.com\/2019\/02\/20\/ebola-pregnancy-reversal\/."},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.044_b0125","article-title":"Predicting Ebola severity: a clinical prioritization score for Ebola Virus disease","volume":"11","author":"Hartley","year":"2017","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20302565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20302565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:15:37Z","timestamp":1777536937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20302565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":25,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0264410X20302565"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prior vaccination with recombinant Vesicular Stomatitis Virus \u2013 Zaire Ebolavirus vaccine is associated with improved survival among patients with Ebolavirus infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}